Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Pfeuffer

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Cell Reports|August 16, 2016
Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal InflammationKonrad Aden, Ateequr Rehman, Maren Falk-Paulsen, et al.
Journal of Neuroinflammation|November 9, 2022
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitisChristina B Schroeter, Leoni Rolfes, K S Sophie Gothan, et al.
Journal of Neurology|February 27, 2026
Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort studyMenekse Oeztuerk, Niklas Huntemann, Lea Gerischer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2018
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosisChristiane Graetz, Adriane Gröger, Felix Luessi, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Journal of Neurology|November 18, 2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessationSteffen Pfeuffer, Rene Schmidt, Frederike Anne Straeten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Cell Reports|August 16, 2016
Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal InflammationKonrad Aden, Ateequr Rehman, Maren Falk-Paulsen, et al.
Journal of Neuroinflammation|November 9, 2022
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitisChristina B Schroeter, Leoni Rolfes, K S Sophie Gothan, et al.
Journal of Neurology|February 27, 2026
Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort studyMenekse Oeztuerk, Niklas Huntemann, Lea Gerischer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2018
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosisChristiane Graetz, Adriane Gröger, Felix Luessi, et al.
Pageof 7